Loading…

Internet-based interdisciplinary therapeutic group (Grupo Interdisciplinar Online, GIO) for perinatal anxiety and depression—a randomized pilot study during COVID-19

Early interventions may promote reductions in mothers’ anxiety-depression (AD) symptoms and improvements in their offspring. This longitudinal randomized research was conducted to assess the effects of interdisciplinary online therapeutic groups (GIO) in at-risk mothers and babies during the COVID-1...

Full description

Saved in:
Bibliographic Details
Published in:Archives of women's mental health 2024-06, Vol.27 (3), p.405-415
Main Authors: Gomà, M., Arias-Pujol, E., Prims, E., Ferrer, J., Lara, S., Glover, V., Martinez, M., Llairó, A., Nanzer, N.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Early interventions may promote reductions in mothers’ anxiety-depression (AD) symptoms and improvements in their offspring. This longitudinal randomized research was conducted to assess the effects of interdisciplinary online therapeutic groups (GIO) in at-risk mothers and babies during the COVID-19 pandemic in a disadvantaged neighborhood in Barcelona (Spain). A total of 135 babies were born from March 2020 to June 2021 in a primary healthcare center of Barcelona (Spain). Pregnant woman and new mothers were screened for AD symptomatology through EPDS and STAI questionnaires. Seventy-two of them met high-risk criteria for AD and were included in the study. They were randomly assigned into the two groups of the study: 40 participants were assigned to GIO, the therapeutic group (TG), while 32 of them were assigned to the control group (CG) and received treatment as usual. The course of the mothers’ symptomatology was assessed, as well as the baby’s development at 6 months old in a blind pediatric follow-up. No differences were found in AD between both groups before the intervention. However, we obtained a significant decrease in AD symptomatology (EPDS p  
ISSN:1434-1816
1435-1102
1435-1102
DOI:10.1007/s00737-023-01412-2